383 related articles for article (PubMed ID: 26745140)
1. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
Zhao S; Tang J; Shao S; Yan Y
Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
[TBL] [Abstract][Full Text] [Related]
2. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.
Park YW; Kim SB; Kwon H; Kang HC; Cho K; Lee KI; Kim YJ; Lee JH
Urology; 2013 Sep; 82(3):674-9. PubMed ID: 23850334
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
[TBL] [Abstract][Full Text] [Related]
4. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
[TBL] [Abstract][Full Text] [Related]
5. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
Lee JH; Kim Y; Park YW; Lee DG
J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
[TBL] [Abstract][Full Text] [Related]
6. The Relationship between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study.
Fu Y; Zhou Z; Yang B; Zhang K; He L; Zhang X
Urol Int; 2016; 97(3):330-335. PubMed ID: 27509202
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
[TBL] [Abstract][Full Text] [Related]
8. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
Lee JH; Kwon H; Park YW
Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
[TBL] [Abstract][Full Text] [Related]
10. Relationship between predictors of the risk of clinical progression of benign prostatic hyperplasia and metabolic syndrome in men with moderate to severe lower urinary tract symptoms.
Kwon H; Kang HC; Lee JH
Urology; 2013 Jun; 81(6):1325-9. PubMed ID: 23602796
[TBL] [Abstract][Full Text] [Related]
11. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
[TBL] [Abstract][Full Text] [Related]
12. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
13. Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia.
Vanella L; Russo GI; Cimino S; Fragalà E; Favilla V; Li Volti G; Barbagallo I; Sorrenti V; Morgia G
Urology; 2014 Jun; 83(6):1444.e7-13. PubMed ID: 24862399
[TBL] [Abstract][Full Text] [Related]
14. Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes.
Caretta N; Vigili de Kreutzenberg S; Valente U; Guarneri G; Pizzol D; Ferlin A; Avogaro A; Foresta C
Andrology; 2015 Nov; 3(6):1062-7. PubMed ID: 26339755
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
[TBL] [Abstract][Full Text] [Related]
16. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome.
Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E
Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.
Russo GI; Vanella L; Castelli T; Cimino S; Reale G; Urzì D; Li Volti G; Gacci M; Carini M; Motta F; Caltabiano R; Puzzo L; Sorrenti V; Morgia G
World J Urol; 2016 Aug; 34(8):1183-92. PubMed ID: 26621207
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
[TBL] [Abstract][Full Text] [Related]
19. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms.
Russo GI; Castelli T; Privitera S; Fragalà E; Favilla V; Reale G; Urzì D; La Vignera S; Condorelli RA; Calogero AE; Cimino S; Morgia G
BJU Int; 2015 Nov; 116(5):791-6. PubMed ID: 25601421
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
